Cargando…
Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
Diarrhea is a common comorbidity present in patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) who are treated with highly active antiretroviral therapy. With a multifactorial etiology, this diarrhea often becomes difficult to manage. In addition, some antiretr...
Autores principales: | Patel, Twisha S, Crutchley, Rustin D, Tucker, Anne M, Cottreau, Jessica, Garey, Kevin W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722035/ https://www.ncbi.nlm.nih.gov/pubmed/23888120 http://dx.doi.org/10.2147/HIV.S30948 |
Ejemplares similares
-
Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
por: Nee, Judy, et al.
Publicado: (2019) -
Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy
por: Clay, Patrick G., et al.
Publicado: (2014) -
Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
por: Crutchley, Rustin D, et al.
Publicado: (2016) -
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
por: Pohlmann, Paula R., et al.
Publicado: (2022) -
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
por: Zhao, Alexa Vyain, et al.
Publicado: (2022)